Company Filing History:
Years Active: 2013-2018
Title: **Inventor Profile: Martin P Maguire**
Introduction
Martin P Maguire is an innovative inventor based in Westmount, Canada. He has made significant contributions to the field of pharmaceuticals, holding a total of 8 patents that pave the way for advancements in medical treatments. His work primarily focuses on novel therapeutic approaches for cardiovascular and related conditions.
Latest Patents
One of Martin's latest patents is titled "Highly water-soluble salts of a short acting phenylalkylamine calcium channel blocker and uses thereof." This invention includes surprisingly water-soluble salts of a phenylalkylamine compound that act as potent antagonists of L-type calcium channels. The aqueous solutions formulated for nasal administration provide a novel therapeutic platform for treating stable angina, migraines, and cardiac arrhythmias, such as paroxysmal supraventricular tachycardia.
Another recent patent is "Short acting phenylalkylamine calcium channel blockers and uses thereof." This invention relates to using a pharmaceutically effective amount of a short-acting calcium channel blocking compound to treat ischemic heart conditions, various cardiac arrhythmias, and hypertensive crises in emergency settings. Additionally, it covers pharmaceutical compositions formulated for such methods and associated kits.
Career Highlights
Martin is currently associated with Milestone Pharmaceuticals Inc., where he utilizes his expertise to further develop innovative healthcare solutions. His dedication to research and development has positioned him as a prominent figure in the pharmaceutical industry.
Collaborations
Throughout his career, Martin has collaborated with talented individuals like Harry Jefferson Leighton and Elise Rioux. These partnerships contribute to the success and depth of exploration in his research endeavors.
Conclusion
Martin P Maguire's contributions through his patents are noteworthy, shining a light on potential advancements in treating cardiovascular diseases. His innovative spirit, along with fruitful collaborations, enhances the future of medical therapies, benefitting patients and healthcare practitioners alike.